Thromboxane A2/Prostaglandin H2 Receptors: A Growing Family of Receptor Subtypes

[1]  E. Hazard,et al.  Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets. , 1991, The Journal of biological chemistry.

[2]  G. FitzGerald,et al.  Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. , 1991, The Journal of pharmacology and experimental therapeutics.

[3]  P. Halushka,et al.  Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. , 1991, Biochemical pharmacology.

[4]  G. Dorn.  Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors. , 1991, The American journal of physiology.

[5]  N. H. Wilson,et al.  Heterogeneity of thromboxane A2 (TP‐) receptors: evidence from antagonist but not agonist potency measurements , 1991, British journal of pharmacology.

[6]  S. Nakanishi,et al.  Cloning and expression of cDNA for a human thromboxane A2 receptor , 1991, Nature.

[7]  G. Dubé,et al.  Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic. , 1991, Molecular pharmacology.

[8]  P. Halushka,et al.  Thromboxane A2 receptors are influenced by cell density in cultured rat aortic smooth muscle cells. , 1991, Life sciences.

[9]  G. FitzGerald,et al.  The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. , 1990, The Journal of biological chemistry.

[10]  P. Halushka,et al.  Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells. , 1990, Life sciences.

[11]  G. Nd.  Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets. , 1989 .

[12]  G. Dorn,et al.  Binding of an [125I] labelled thromboxane A2/prostaglandin H2 receptor agonist to baboon platelets. , 1989, Prostaglandins.

[13]  P. Halushka,et al.  Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. , 1989, The Journal of pharmacology and experimental therapeutics.

[14]  H. Arita,et al.  Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells. , 1989, Biochemical pharmacology.

[15]  P. Halushka,et al.  Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors. , 1989, The Journal of pharmacology and experimental therapeutics.

[16]  C. Yoakim,et al.  Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor. , 1989, Biochimica et biophysica acta.

[17]  P. Halushka,et al.  Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Arita,et al.  Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145. , 1989, Biochemical pharmacology.

[19]  B. Wílkes,et al.  Characterization of glomerular thromboxane receptor sites in the rat. , 1989, The American journal of physiology.

[20]  R. Frizzell,et al.  A volume-sensitive chloride conductance in human colonic cell line T84. , 1989, The American journal of physiology.

[21]  S. Narumiya,et al.  Expression of thromboxane A2 receptor in cultured human erythroleukemia cells and its induction by 12-O-tetradecanoylphorbol-13-acetate. , 1989, Biochemical and biophysical research communications.

[22]  E. Liu,et al.  Evidence for functional thromboxane A2-prostaglandin H2 receptors in human placenta. , 1989, The American journal of physiology.

[23]  B. Berkowitz,et al.  Endothelial thromboxane receptors: biochemical characterization and functional implications. , 1989, Biochemical and biophysical research communications.

[24]  S. Narumiya,et al.  [3H]S-145 and [125I]I-S-145-OH: new radioligands for platelet thromboxane A2 receptor with low nonspecific binding and high binding affinity for various receptor preparations. , 1989, Eicosanoids.

[25]  J. Dolan,et al.  Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists. , 1988, European journal of pharmacology.

[26]  E. Liu,et al.  Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets. , 1988, The Journal of pharmacology and experimental therapeutics.

[27]  P. Halushka,et al.  Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. , 1988, European journal of pharmacology.

[28]  H. Arita,et al.  Identification of thromboxane A2 receptor in cultured vascular endothelial cells of rat aorta. , 1988, Biochemical and biophysical research communications.

[29]  H. Arita,et al.  Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta. , 1988, Biochemical and biophysical research communications.

[30]  J. Smith,et al.  Receptor-mediated effects of a PGH2 analogue (U 46619) on human platelets. , 1987, The American journal of physiology.

[31]  P. Halushka,et al.  Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets. , 1987, Prostaglandins.

[32]  P. Halushka,et al.  Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors. , 1987, Federation proceedings.

[33]  P. Halushka,et al.  Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets. , 1986, European journal of pharmacology.

[34]  S. Narumiya,et al.  Binding of a radioiodinated 13‐azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species , 1986, British journal of pharmacology.

[35]  G. L. Le Breton,et al.  Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548). , 1986, Thrombosis research.

[36]  P. Halushka,et al.  Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. , 1985, The Journal of pharmacology and experimental therapeutics.

[37]  P. Halushka,et al.  Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets. , 1985, Molecular pharmacology.

[38]  P. Halushka,et al.  Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. , 1985, The Journal of pharmacology and experimental therapeutics.

[39]  P. Halushka,et al.  Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins. , 1985, European journal of pharmacology.

[40]  D. Miller,et al.  Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses. , 1985, Biochemical pharmacology.

[41]  G. L. Le Breton,et al.  Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes. , 1983, Biochimica et biophysica acta.

[42]  A. M. Lefer,et al.  Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues , 1983, British journal of pharmacology.

[43]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[44]  G. L. Le Breton,et al.  13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Needleman,et al.  Thromboxanes: selective biosynthesis and distinct biological properties. , 1976, Science.

[46]  R. Ross.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. , 1971 .